Clinical Trials Sponsored by ProFem GmbH

Total 3982 results

ProFem GmbH

Completed

ProF-001_Phase IIa

Vulvovaginal Candidiasis (VVC)

Austria
ProFem GmbH
Montavit Ges.m.b.H.

Active, not recruiting

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

Recurrent Vulvovaginal Candidiasis

Austria, Poland, Slovakia
BSN Medical GmbH
proDERM GmbH

Completed

Feasibility Study Focusing on Fit of Made-to-measure Compression Garments in Healthy Subjects II

Product Use Issue

Germany
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Skin Aging

Germany
Amazentis SA
proDERM GmbH

Completed

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Erythema | Skin Inflammation | Sun Damaged Skin

Germany
Almirall, S.A.
proDERM GmbH

Completed

Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test

Psoriasis

Germany
Almirall, S.A.
proDERM GmbH

Completed

Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test (PPT4)

Psoriasis

Germany
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of Four Skin Health Products

Skin Aging | Anti-Aging

Germany
Amazentis SA
proDERM GmbH

Completed

Anti-Wrinkle Efficacy Study of an Eye-Cream

Aging | Wrinkle

Germany
Prof. Dr. Thomas Forst

Completed

Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

Type2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Terminated

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Active, not recruiting

Clinical Experimental Study to Investigate Specific Features of ClampArt®

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

Diabetes Mellitus

Germany
Sanofi
Profil GmbH, Neuss, Germany

Completed

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (RESTORE)

Diabetes Mellitus, Type 2

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus (DLW)

Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Explorative Assessment of Biomarkers in Overweight and Obese Subjects

Prediabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Empagliflozin and Sympathetic Nerve Traffic

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test (DXM2)

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Withdrawn

An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms

Diabetes Type 1 | Prediabetes | Diabetes Type 2
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology

Type 2 Diabetes Mellitus

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
proDERM GmbH

Completed

Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness

Vaginal Atrophy

Germany
AIO-Studien-gGmbH
Servier Deutschland GmbH; Crolll Gmbh

Active, not recruiting

2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy (PREDICT)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

Type 2 Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers

Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH
Pfizer

Terminated

DIATOR-Diabetes Intervention With Atorvastatin

Type 1 Diabetes

Germany
VisionHealth GmbH
Thoraxklinik-Heidelberg gGmbH

Recruiting

Effects of the Kata® Inhalations-App on Inhaler Handling Errors, Adherence, and Asthma Control in Patients With Asthma.

Asthma

Germany
Saniona
Profil Institut für Stoffwechselforschung GmbH

Completed

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying

Diabetes Mellitus

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N

Healthy Volunteer

Germany
Prof. Kristian Reich

Completed

Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP) (METOP)

Psoriasis Vulgaris

Germany
Spiden AG
Profil Institut für Stoffwechselforschung GmbH

Recruiting

Spiden Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Type 1 Diabetes | Type2diabetes

Germany
Zealand Pharma
Profil Institut für Stoffwechselforschung GmbH

Recruiting

A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Safety and Tolerability

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects (RHINE-4)

Healthy Volunteers

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

Healthy Volunteer

Germany
AIO-Studien-gGmbH
Pfizer; Crolll Gmbh

Recruiting

Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy (PREPARE)

Renal Cell Carcinoma, Metastatic | Renal Cell Cancer, Recurrent

Germany
AIO-Studien-gGmbH
Celgene; ClinAssess GmbH

Completed

Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer (NEONAX)

Resectable Pancreatic Cancer | Ductal Adenocarcinoma of the Pancreas

Germany
Thoraxklinik-Heidelberg gGmbH
Erbe Elektromedizin GmbH

Completed

EBUS Guided Cryobiopsies With Ultrathin Cryoprobe in Patients With Peripheral Pulmonary Nodules - a Feasibility Study

Transbronchial Cryobiopsy

Germany
AIO-Studien-gGmbH
Sanofi; ClinAssess GmbH

Terminated

A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) (CaBaMet)

Breast Cancer | Lung Cancer | Recurrent Brain Metastases | Progressive Brain Metastases

Germany
Reckitt Benckiser Healthcare (UK) Limited
proDERM GmbH

Completed

A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants.

Vaginal Dryness | Dyspareunia

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30

Healthy Volunteer

Germany
Medtronic Diabetes
Profil Institut für Stoffwechselforschung GmbH

Completed

New Generation Enlite Accuracy Study

Diabetes
Profil Institut für Stoffwechselforschung GmbH
European Union

Completed

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Diabetes Mellitus Type 1

Germany
AIO-Studien-gGmbH
Amgen; ClinAssess GmbH

Completed

FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) (VOLFI)

Metastatic Colorectal Cancer

Germany
AIO-Studien-gGmbH
Amgen; ClinAssess GmbH

Completed

Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer (PanaMa)

Metastatic Colorectal Cancer

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Mundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbH

Completed

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Germany
Profil Institut für Stoffwechselforschung GmbH
OptiScan Biomedical Corporation

Completed

Performance Study Using the OptiScanner on Healthy Diabetics

Diabetes

Germany
AIO-Studien-gGmbH
Celgene Corporation; ClinAssess GmbH

Completed

First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine (ALPACA)

Adenocarcinoma of the Pancreas | Metastatic Pancreatic Cancer

Germany

Clinical Trials Sponsored by ProFem GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations